TYLER HAUSWALD: Open Payments
NPI 1740270446 · WAHOO, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98 in 6 payments from 5 companies in 2025. Trend: 2023 $376 · 2024 $302 · 2025 $98
Food & beverage: $98
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VAXNEUVANCE, LEQVIO, VRAYLAR, MOUNJARO, REXULTI, UBRELVY.
Industry payments across NE — which companies pay providers there.
